Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Bharat Biotech in-licences GSK's Shigella vaccine candidate

نشر بتاريخ

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

جارٍ التحميل...

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

International

‘Remains hopeful’: Sean ‘Diddy’ Combs’ lawyer seeks Trump’s pardon; Combs to remain jailed till sentencing

Nicole Westmoreland, part of Sean 'Diddy' Combs' legal team, says they contacted the Trump...

بواسطة 0 2

International

Baby bonus: China offers subsidy to boost birth rate; why 'lie flat' gen isn't convinced

In the last week of July, the government announced a new plan to increase the birth rate. Parents...

بواسطة 0 2

Business

Gold price prediction today: Where is gold rate headed in the near-term amidst Trump's tariff war? Here’s the outlook

Gold prices are expected to remain range-bound with limited upward movement in the near term,...

بواسطة 0 3

Business

Stock market today: Nifty50 opens flat; BSE Sensex near 80,700 ahead of RBI policy decision

Stock market today: Indian equity benchmark indices, Nifty50 and BSE Sensex, opened in flat in...

بواسطة 0 3

Sports

Son Heung-min joins LAFC in blockbuster move, ends decade-long Spurs chapter

Son Heung-min has made a high-profile move to Los Angeles FC from Tottenham Hotspur after a...

بواسطة 0 5